PNC Financial Services Group
AVIR icon

PNC Financial Services Group’s Atea Pharmaceuticals AVIR Stock Holding History

PNC Financial Services Group’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$23.7K Buy
4,544
+1,759
+63% +$9K ﹤0.01% 3774
2026
Q2 		$13K Sell
2,785
-291
-9% -$1.45K ﹤0.01% 3975
2026
Q1 		$16.5K Buy
3,076
+231
+8% +$1.06K ﹤0.01% 3769
2025
Q4 		$10.2K Sell
2,845
-906
-24% -$2.88K ﹤0.01% 3940
2025
Q3 		$10.9K Sell
3,751
-543
-13% -$1.85K ﹤0.01% 3903
2025
Q2 		$15.5K Buy
4,294
+3,402
+381% +$10.1K ﹤0.01% 3687
2025
Q1 		$2.67K Buy
892
+843
+1,720% +$2.63K ﹤0.01% 4266
2024
Q4 		$164 Sell
49
-1,467
-97% -$4.88K ﹤0.01% 4666
2024
Q3 		$5.08K Buy
1,516
+1,260
+492% +$4.57K ﹤0.01% 4034
2024
Q2 		$847 Buy
256
+157
+159% +$585 ﹤0.01% 4460
2024
Q1 		$400 Buy
99
+25
+34% +$98 ﹤0.01% 4523
2023
Q4 		$226 Buy
+74
New +$224 ﹤0.01% 4478
2022
Q4 		– Sell
-5,000
Closed -$28K – 4763
2022
Q3 		$28K Hold
5,000
– – ﹤0.01% 3275
2022
Q2 		$36K Hold
5,000
– – ﹤0.01% 3176
2022
Q1 		$36K Sell
5,000
-132,050
-96% -$897K ﹤0.01% 3278
2021
Q4 		$1.22M Buy
137,050
+132,050
+2,641% +$2.06M ﹤0.01% 1173
2021
Q3 		$175K Hold
5,000
– – ﹤0.01% 2280
2021
Q2 		$107K Hold
5,000
– – ﹤0.01% 2614
2021
Q1 		$309K Hold
5,000
– – ﹤0.01% 1888
2020
Q4 		$209K Buy
+5,000
New +$161K ﹤0.01% 2044

Other funds holding AVIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $188M AUM 88.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $149M AUM 35.54% 1-Year Est. Return
Banque Pictet & Cie
Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

PNC Financial Services Group's AVIR Position: Q3 2026 in Review

PNC Financial Services Group increased its Atea Pharmaceuticals (AVIR) stake by 63% in Q3 2026, buying an estimated $9K and bringing the position to 4,544 shares worth $23.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3774.

PNC Financial Services Group first reported a position in AVIR in Q4 2020 and has held it in 20 quarters since. The position peaked at $1.22M in Q4 2021. 62 funds tracked by Wall St. Rank hold AVIR as of Q3 2026.

  • PNC Financial Services Group held 4,544 shares of Atea Pharmaceuticals worth $23.7K as of Q3 2026.
  • PNC Financial Services Group bought 1,759 Atea Pharmaceuticals shares in Q3 2026, an estimated $9K.
  • Atea Pharmaceuticals made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #3774 holding.
  • PNC Financial Services Group first reported a position in Atea Pharmaceuticals in Q4 2020 and has held it in 20 quarters since.
  • PNC Financial Services Group's Atea Pharmaceuticals position peaked at $1.22M in Q4 2021.
  • 62 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.